Furthermore, Jingbo Sun et al. observed that hyper-expression of CENPF in breast cancer was linked to poor prognostic and bone metastases [18], and Hongjin Chen et al. proposed the involvement of the CENPF-pERK-NEK2 pathway in HCC development [19]. The gene discussed is NEK2; the disease is breast carcinoma.